BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pahari H, Peer JA, Tripathi S, Singhvi SK, Dhir U. Downstaging of advanced hepatocellular carcinoma followed by liver transplantation using immune checkpoint inhibitors: Where do we stand? World J Gastrointest Pharmacol Ther 2024; 15(5): 97570 [PMID: 39281264 DOI: 10.4292/wjgpt.v15.i5.97570]
URL: https://www.wjgnet.com/2150-5349/full/v15/i5/97570.htm
Number Citing Articles
1
Mingyao Huang, Quansong Ji, Huiyan Huang, Xiaoqian Wang, Lin Wang. Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modificationGut Microbes 2025; 17(1) doi: 10.1080/19490976.2025.2486519
2
Erin M. Duggan, Nishtha Singh, Joanna K. Weeks, Adam Talenfeld, Benjamin May, Resmi Charalel, Ian Dinmore, Sarah Stucky, Tea Binder, Alexander J. Berman, Yana Glemaud, Arush Anand, Anthony Choi, Rebecca Craig-Schapiro, Dustin Carpenter, Benjamin Samstein, Juan P. Rocca. Effectiveness of Downstaging Advanced Hepatocellular Carcinoma for Liver Transplantation: Insights from a Decade of Single-Center ExperienceDigestive Disease Interventions 2026;  doi: 10.1055/a-2779-5353
3
Hao Liu, Isabel Neckermann, Jason Mial‐Anthony, Charbel Elias, Abiha Abdullah, Vrishketan Sethi, Christopher Kaltenmeier, Amaan Rahman, Eishan Ashwat, Packiaraj Godwin, Subedi Sabin, Timothy Fokken, Shwe Han, Xingyu Zhang, Stalin Dharmayan, Jaideep Behari, Stela Celaj, Michele Molinari. Optimizing Liver Transplant Allocation for Hepatocellular Carcinoma: Development and Validation of a Survival Benefit‐Based ModelClinical Transplantation 2026; 40(3) doi: 10.1111/ctr.70488
Write to the Help Desk